no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
1 |
Advantage of FMISO-PET over FDG-PET for predicting histological response to preoperative chemotherapy in patients with oral squamous cell carcinoma
|
Sato, Jun |
|
2014 |
41 |
11 |
p. 2031-2041 |
article |
2 |
Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer’s patients
|
Choo, IL Han |
|
2014 |
41 |
11 |
p. 2120-2126 |
article |
3 |
213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience
|
Kratochwil, C. |
|
2014 |
41 |
11 |
p. 2106-2119 |
article |
4 |
Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys
|
Tsukada, Hideo |
|
2014 |
41 |
11 |
p. 2127-2136 |
article |
5 |
Do CSF levels of t-Tau, p-Tau and β1-42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease
|
Chiaravalloti, Agostino |
|
2014 |
41 |
11 |
p. 2137-2143 |
article |
6 |
EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)
|
Todde, Sergio |
|
2014 |
41 |
11 |
p. 2175-2185 |
article |
7 |
Erratum to: Do CSF levels of t-Tau, p-Tau and β1–42 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease
|
Chiaravalloti, Agostino |
|
2014 |
41 |
11 |
p. 2165-2166 |
article |
8 |
Erratum to: Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
|
Caicedo, Carlos |
|
2014 |
41 |
11 |
p. 2164 |
article |
9 |
Evaluation of response to immunotherapy: new challenges and opportunities for PET imaging
|
Gilardi, Laura |
|
2014 |
41 |
11 |
p. 2090-2092 |
article |
10 |
FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment
|
Basu, Sandip |
|
2014 |
41 |
11 |
p. 2158-2160 |
article |
11 |
18F-Fluorocholine PET/CT for localization of hyperfunctioning parathyroid tissue in primary hyperparathyroidism: a pilot study
|
Lezaic, Luka |
|
2014 |
41 |
11 |
p. 2083-2089 |
article |
12 |
Furosemide diminishes 18F-fluoroethylcholine uptake in prostate cancer in vivo
|
Rischke, H. Christian |
|
2014 |
41 |
11 |
p. 2074-2082 |
article |
13 |
Ideas from the second UEMS conference on CME/CPD: new EU directives on a patients’ rights in cross-border healthcare and professional qualifications
|
Varetto, Teresio |
|
2014 |
41 |
11 |
p. 2169-2173 |
article |
14 |
Impact of 18F-FDG PET/CT on the management of adrenocortical carcinoma: analysis of 106 patients
|
Takeuchi, Satoshi |
|
2014 |
41 |
11 |
p. 2066-2073 |
article |
15 |
Interim FDG PET scans in lymphoma: SUV measurement error may impair qPET methodology
|
Laffon, Eric |
|
2014 |
41 |
11 |
p. 2154 |
article |
16 |
Introduction to EANM guideline for the preparation of an Investigational Medicinal Product Dossier (IMPD)
|
Chiti, Arturo |
|
2014 |
41 |
11 |
p. 2174 |
article |
17 |
Metabolic parameters using 18F-FDG PET/CT correlate with occult lymph node metastasis in squamous cell lung carcinoma
|
Kim, Do-Hoon |
|
2014 |
41 |
11 |
p. 2051-2057 |
article |
18 |
Molecular imaging: the emerging role of optical imaging in nuclear medicine
|
Leeuwen, Fijs W. B. van |
|
2014 |
41 |
11 |
p. 2150-2153 |
article |
19 |
Paolo Pozzilli, Andrea Lenzi, Bart L. Clarke, William F. Young Jr. (Eds): Imaging in Endocrinology
|
Amato, Manuela |
|
2014 |
41 |
11 |
p. 2161 |
article |
20 |
Performance of FDG PET/CT at initial diagnosis in a rare lymphoma: nodular lymphocyte-predominant Hodgkin lymphoma
|
Grellier, Jean François |
|
2014 |
41 |
11 |
p. 2023-2030 |
article |
21 |
Pretherapy metabolic tumour volume is an independent predictor of outcome in patients with diffuse large B-cell lymphoma
|
Sasanelli, Myriam |
|
2014 |
41 |
11 |
p. 2017-2022 |
article |
22 |
Pretreatment metabolic tumour volume is predictive of disease-free survival and overall survival in patients with oesophageal squamous cell carcinoma
|
Lemarignier, Charles |
|
2014 |
41 |
11 |
p. 2008-2016 |
article |
23 |
Prognostic value of tumour blood flow, [18F]EF5 and [18F]FDG PET/CT imaging in patients with head and neck cancer treated with radiochemotherapy
|
Komar, Gaber |
|
2014 |
41 |
11 |
p. 2042-2050 |
article |
24 |
Radiopharmaceuticals are special, but is this recognized? The possible impact of the new Clinical Trials Regulation on the preparation of radiopharmaceuticals
|
Decristoforo, C. |
|
2014 |
41 |
11 |
p. 2005-2007 |
article |
25 |
Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
|
Caicedo, Carlos |
|
2014 |
41 |
11 |
p. 2058-2065 |
article |
26 |
Sources of variability in FDG PET imaging and the qPET value: reply to Laffon and Marthan
|
Hasenclever, Dirk |
|
2014 |
41 |
11 |
p. 2155-2157 |
article |
27 |
The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition
|
Herholz, K. |
|
2014 |
41 |
11 |
p. 2144-2149 |
article |
28 |
Weibo Cai (Ed.): Engineering in Translational Medicine
|
Mansi, Luigi |
|
2014 |
41 |
11 |
p. 2163 |
article |
29 |
Widespread vascular inflammation in a patient with antineutrophil cytoplasmic antibody-associated vasculitis as detected by positron emission tomography
|
Salomäki, Soile P. |
|
2014 |
41 |
11 |
p. 2167-2168 |
article |
30 |
Wieslaw L. Nowinski and Beng Choon Chua (eds): The Human Brain in 1969 Pieces. Structure, Vasculature, Tracts, Cranial Nerves, Systems, Head Muscles, and Glands, Version 2.0
|
Mansi, Luigi |
|
2014 |
41 |
11 |
p. 2162 |
article |
31 |
89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
|
Pandit-Taskar, Neeta |
|
2014 |
41 |
11 |
p. 2093-2105 |
article |